CEL-SCI Prices $5 Million Offer (NYSE:CVM)

CEL-SCI(New York Stock Exchange:the biography), a phase III cancer immunotherapy company, Reasonably priced Public offering of 16.13 million shares.

Each share of common stock (or pre-funded warrant) will be sold at a public offering price of $0.31 per share (including the exercise price of the pre-funded warrant).